DeBoer MD, Li Y, Cohn S
Its injection is a compounded form of semaglutide, the medicine sold by Novo Nordisk as Ozempic and Wegovy, which remains on the FDA's shortage list
Headache and flushing: Occasionally reported with sermorelin, typically mild and temporary
Glp-1 effects on islets: Hormonal, neuronal, or paracrine
Additionally, whilst the glucose-dependent mechanisms of both drugs mean hypoglycaemia risk remains low when used without insulin or sulphonylureas, combining them with other glucose-lowering agents could increase this risk
In developed countries, there are numerous hypotheses about the pathophysiological background of frequent diseases, such as obesity, asthma, cancer, autoimmune diseases, and allergy